Dharmaj Crop Guard Ltd (DHARMAJ)

Chemicals · Agro Chemicals · NSE · Updated 1 September 2026
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
₹269 ↓ 27.3% (1Y)

🎯 Key Takeaways

  • Dharmaj Crop Guard Ltd is in a growth phase driven by operational scale-up and export expansion, with management targeting sustained double-digit revenue growth and margin improvement over the next 2-3 years. The company has demonstrated strong profitability momentum, supported by backward integration, capacity expansion, and international market penetration, while maintaining a conservative capital structure.
  • Revenue grew 63.6% QoQ to ₹382 in Q1FY27.
  • ⚠️ 1) Monsoon volatility could impact agricultural demand and input availability, affecting revenue stability. 2) Global supply chain disruptions may pre
Market Cap
₹909
P/E Ratio
15.1
P/B Ratio
2.31
ROE
15.3%
ROCE
18.9%
Debt/Equity
0.29
Promoter
70.4%

📖 The Story

Dharmaj Crop Guard Ltd is in a growth phase driven by operational scale-up and export expansion, with management targeting sustained double-digit revenue growth and margin improvement over the next 2-3 years. The company has demonstrated strong profitability momentum, supported by backward integration, capacity expansion, and international market penetration, while maintaining a conservative capital structure.

📰 What's Happening

In the latest quarter (Q1FY27), the company reported revenue of ₹382 crores with an operating profit margin of 13.7% and net profit of ₹38 crores, reflecting consistent profitability across quarters. FY26 revenue grew 20% YoY to ₹11,380 crores, driven by 37% growth in active ingredients and strong technical plant performance, with EBITDA up 34% to ₹1,005 crores and gross margins expanding to 23%. Management expects 18-20% revenue growth in FY27, supported by the commissioning of a new herbicide facility in Kerala by Q3 FY27 and improved capacity utilization. Export revenue grew 58% to ₹834 crores in FY26, with plans to scale African and Latin American markets and register 150 new products. The company has also expanded its distribution network to 19,300+ retail touchpoints and invested in backward integration to reduce input costs.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

MetricSep 2025Dec 2025Mar 2026Jun 2026
Revenue347190234382
Operating Profit272653
OPM %7.8%1.3%2.5%13.7%
Net Profit171438
EPS₹5.13₹0.22₹1.17₹11.28

The company's financial trajectory shows consistent improvement in profitability and operational efficiency, with PAT margin expanding from 3.7% to 4.8% and ROCE holding strong at 18-19% over the past year. Quarterly results indicate stable performance with sequential growth in revenue and margins, particularly in Q4 FY26 where revenue rose to ₹234 crores with EBITDA at ₹101 crores. Management attributes this growth to scale, backward integration, and new facility commissioning, which are expected to drive further margin expansion and operational resilience in FY27.

🔮 Management Outlook & What's Next

Management has provided forward-looking guidance, targeting 18-20% revenue growth in FY27 and EBITDA margin expansion to 8-10% over 2-3 years, supported by the new herbicide facility in Kerala and improved capacity utilization. They also expect sustained double-digit topline growth every three years, driven by export expansion, product diversification, and digital distribution initiatives. The company emphasizes operational scale, backward integration, and market expansion as key pillars of its growth strategy, with no major M&A or restructuring plans disclosed.

Extracted from official company announcements. Not StockFin.ai's opinion.

🏦 Balance Sheet (₹ Cr)

ItemMar 2025Mar 2026Mar 2026
Equity Capital343434
Reserves361411415
Borrowings116139132
Total Liabilities733956841
Fixed Assets315313310
Investments000
Total Assets733956841

The balance sheet reflects a strong and stable capital structure, with gross debt at 0.29x and consistent equity and reserve growth. Total assets have increased from ₹733 crores in March 2025 to ₹956 crores in March 2026, while borrowings remain low and stable at around ₹130-140 crores. This indicates disciplined capital allocation, with no aggressive leverage and a focus on funding growth through internal cash flows and retained earnings rather than debt.

💰 Cash Flow Statement (₹ Cr)

ItemMar 2025
Operating+39
Investing-33
Financing-9
Net Cash Flow-3

👥 Shareholding Pattern

CategoryQ2FY26Q3FY26Q4FY26Q1FY27
Promoters70.4%70.4%70.4%70.4%
FII3.1%3.5%3.1%3.1%
DII0.5%0.5%0.5%0.5%
Public20.7%20.3%20.3%20.6%
# Shareholders30,28428,99027,53726,567

Institutional investor interest remains stable but modest, with FII holding at 3.13% in Q1FY27 and DII at 0.47-0.5% over the past year, while promoter holding remains steady at 70.4%. The number of public shareholders has slightly declined from 30,284 to 26,567, suggesting possible consolidation, but the company maintains a broad retail base. There are no signs of significant institutional accumulation or exit, indicating neutral to slightly positive investor sentiment without aggressive positioning.

⚖️ Peer Comparison — Agro Chemicals

Company MCap (₹ Cr) P/E ROCE ROE D/E
UPL 47,485 23.3 11.4% 6.7% 0.64
PIIND 36,382 31.2 13.3% 10.4% 0.02
SUMICHEM 25,753 44.4 23.1% 17.1% 0.00
BAYERCROP 17,844 369.7 3.3% 1.2% 0.00
SHARDACROP 6,918 11.1 25.8% 20.0% 0.00
DHANUKA 4,360 14.9 27.5% 21.2% 0.03
RALLIS 4,041 24.6 12.9% 9.7% 0.03
NACLIND 3,988 340.5 6.0% 1.8% 0.44
BHAGCHEM 3,683 134.0 6.1% 3.9% 0.33
GSPCROP 2,976 26.0 22.5% 21.9% 0.66

🔗 Peer Stock Analyses

⚠️ Risk Factors

1) Monsoon volatility could impact agricultural demand and input availability, affecting revenue stability. 2) Global supply chain disruptions may pressure input costs and margins despite backward integration efforts. 3) Export growth faces execution risks due to regulatory hurdles and geopolitical sensitivities in target markets like Africa and Latin America. 4) High promoter concentration (70.4%) may limit float liquidity and increase governance scrutiny.

📋 Recent Filings

🧠 Analyst's Read

Dharmaj Crop Guard is executing a disciplined growth strategy with improving profitability and operational scale, supported by capacity expansion and export ambitions. Investors should monitor the timely commissioning of the Kerala facility and margin trajectory in FY27, as these will be critical to sustaining growth momentum amid agricultural cyclicality and global supply chain uncertainties.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

Sign Up Free — Unlock Full Analysis

2 free AI queries per day.

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-01.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when DHARMAJ files new disclosures

Track DHARMAJ filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track DHARMAJ — Free

Free account · 2 AI queries/day